Yeah, agree totally. Brokers need to practice reputational management and if they can forecast a 20% rise and come in conservatively correct, that's a ton better than overstating the target. They can always adjust upwards later on.
- Forums
- ASX - By Stock
- WAF
- Ann: Quarterly Cashflow Report
Ann: Quarterly Cashflow Report, page-43
-
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WAF (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.52 |
Change
0.020(1.33%) |
Mkt cap ! $1.725B |
Open | High | Low | Value | Volume |
$1.52 | $1.54 | $1.51 | $2.746M | 1.806M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 43867 | $1.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.52 | 47074 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 30787 | 1.515 |
20 | 81236 | 1.510 |
18 | 115625 | 1.505 |
14 | 137255 | 1.500 |
11 | 407255 | 1.495 |
Price($) | Vol. | No. |
---|---|---|
1.520 | 51125 | 34 |
1.525 | 126483 | 28 |
1.530 | 202302 | 22 |
1.535 | 357242 | 14 |
1.540 | 75324 | 8 |
Last trade - 11.32am 16/07/2024 (20 minute delay) ? |
Featured News
WAF (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online